Alan C. Foster
Plus aucun poste en cours
Profil
Alan C.
Foster is the founder of 2904357 Canada, Inc. founded in 1974.
He worked as Vice President-Pharmacology at Allergan, Inc. and Vice President-Neuroscience at Neurocrine Biosciences, Inc. He served as Chief Scientific Officer at Otonomy, Inc. from 2014 to 2022.
Dr. Foster received his undergraduate and doctorate degrees from Southampton Business School.
Anciens postes connus de Alan C. Foster
| Sociétés | Poste | Fin |
|---|---|---|
| OTONOMY | Directeur Technique/Scientifique/R&D | 15/12/2022 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
2904357 Canada, Inc.
 2904357 Canada, Inc. Personnel ServicesCommercial Services 2904357 Canada, Inc. offers placement for drivers, office and warehouse personnel. Its divisions include transport, work-force and office. The transport division specializes in hiring drivers; the work-force division supplies clerical workers, and people for physical and manual labour and the office division supplies receptionists, office workers, customer service representatives, accounting clerks and dispatch agents. The company was founded by Alan C. Foster in 1974 and is headquartered in Montreal, Canada. | Fondateur | - |
Formation de Alan C. Foster
| Southampton Business School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
2904357 Canada, Inc.
2904357 Canada, Inc. Personnel ServicesCommercial Services 2904357 Canada, Inc. offers placement for drivers, office and warehouse personnel. Its divisions include transport, work-force and office. The transport division specializes in hiring drivers; the work-force division supplies clerical workers, and people for physical and manual labour and the office division supplies receptionists, office workers, customer service representatives, accounting clerks and dispatch agents. The company was founded by Alan C. Foster in 1974 and is headquartered in Montreal, Canada. | Commercial Services |
